NVNovartis AG NVSEF · OTC
$143.90 -0.29% (-$0.42)
- Market cap
- $292.6B
- Enterprise value
- $333.9B
- P/E
- 23.1x
- Forward P/E
- 16.9x
- PEG
- 0.9x
- P/S
- 5.3x
- P/FCF
- 18.3x
- EV/EBITDA
- 14.7x
- ROIC
- 13.7%
- Bruto marža
- 74.3%
- Neto marža
- 23.1%
- Dividend yield
- 3.08%
- Payout ratio
- 71.3%
- Neto dolg/EBITDA
- 1.8x
- Beta
- 0.49
- Free float
- 84.6%
O podjetju
Novartis AG is a Swiss multinational pharmaceutical company specializing in the development, manufacturing, and distribution of drugs and healthcare products. Founded in 1996 through the merger of Ciba-Geigy and Sandoz, the company is headquartered in Basel, Switzerland. Novartis focuses on treating a wide range of diseases, including cancer, cardiovascular conditions, neurological disorders, and more. The company is one of the largest global players in pharmaceutical research and development.
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Vasant Narasimhan
Employees
75,267
Headquarters
Basel
Vrednotenje
Je današnja cena primerna?
Rast in ocene
Ali podjetje raste in kaj sledi?
Donosnost in kakovost
Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?
Finančno zdravje
Ali zmore svoj dolg?
Kapital in dividende
Kaj podjetje počne z zasluženim denarjem?
Analitiki
Kaj menijo strokovnjaki in ali se to spreminja?
Lastniki in insajderji
Kdo ima delnice in kaj počne vodstvo?
Segmenti
Kateri del podjetja raste?
Primerjava s konkurenco
Kako se primerja s podobnimi podjetji?
Cena in tveganje
Kako se delnica obnaša?
Izkazi
Vse številke